Kenneth W. Bair
Forma Therapeutics (United States)(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Sirtuins and Resveratrol in Medicine, Synthetic Organic Chemistry Methods, Biochemical and Molecular Research, Chemical Synthesis and Analysis
Most-Cited Works
- → Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway(2004)476 cited
- → Molecular basis of USP7 inhibition by selective small-molecule inhibitors(2017)452 cited
- → Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists(1999)318 cited
- → Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase(2003)307 cited
- → Proteomics-based Target Identification(2003)144 cited
- → Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824(2004)134 cited
- → N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)(2003)129 cited
- → Inhibitors of Human Histone Deacetylase: Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates(2002)114 cited
- → Trifyl activation in organic synthesis(1977)105 cited
- → Structural and Conformational Requirements for High-Affinity Binding to the SH2 Domain of Grb2(1999)88 cited